Partitioning of phytocannabinoids between faeces and water - Implications for wastewater-based epidemiology.

11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) Cannabis Solution equilibria Suspended particulate matter Wastewater analysis

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
20 Jan 2022
Historique:
received: 06 08 2021
revised: 06 09 2021
accepted: 07 09 2021
pubmed: 19 9 2021
medline: 25 11 2021
entrez: 18 9 2021
Statut: ppublish

Résumé

Evaluating consumption estimates for lipophilic drugs in wastewater has proven to be a challenge. A common feature for these compounds is that they are excreted in faeces and in conjugated form in urine. Limited research with no obvious experimental evidence has been conducted to investigate the degree to which faecal-bound chemical markers contribute towards mass loads in wastewater. Cannabis chemical markers, known as phytocannabinoids, have been suggested in literature to fall into this category. In this study, cannabis users (n = 9) and non-cannabis users (n = 5) were recruited and provided faecal and urine samples after using the substance. The common chemical markers of cannabis consumption, 11-nor-9-carboxy-Δ

Identifiants

pubmed: 34536871
pii: S0048-9697(21)05346-8
doi: 10.1016/j.scitotenv.2021.150269
pii:
doi:

Substances chimiques

Cannabinoids 0
Water 059QF0KO0R
Dronabinol 7J8897W37S

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150269

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest For the submission our manuscript entitled ‘Partitioning of phytocannabinoids between faeces and water – implications for wastewater-based epidemiology’ to the Journal of Science of the Total Environment. We here by acknowledge the following.

Auteurs

Aaron J Pandopulos (AJ)

University of South Australia, Clinical and Health Sciences (CHS), Health and Biomedical Innovation, South Australia 5000, Australia.

Bradley S Simpson (BS)

University of South Australia, Clinical and Health Sciences (CHS), Health and Biomedical Innovation, South Australia 5000, Australia.

Jason M White (JM)

University of South Australia, Clinical and Health Sciences (CHS), Health and Biomedical Innovation, South Australia 5000, Australia.

Richard Bade (R)

University of South Australia, Clinical and Health Sciences (CHS), Health and Biomedical Innovation, South Australia 5000, Australia.

Cobus Gerber (C)

University of South Australia, Clinical and Health Sciences (CHS), Health and Biomedical Innovation, South Australia 5000, Australia. Electronic address: cobus.gerber@unisa.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH